X-154534125-C-T

Variant summary

Our verdict is Likely pathogenic. The variant received 7 ACMG points: 8P and 1B. PM1PM5PP2PP3_ModeratePP5BS2_Supporting

The NM_001360016.2(G6PD):​c.680G>A​(p.Arg227Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000636 in 1,210,410 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 30 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R227L) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.000071 ( 0 hom., 6 hem., cov: 23)
Exomes 𝑓: 0.000063 ( 0 hom. 24 hem. )

Consequence

G6PD
NM_001360016.2 missense

Scores

7
8
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:4U:2O:1

Conservation

PhyloP100: 5.50

Publications

58 publications found
Variant links:
Genes affected
G6PD (HGNC:4057): (glucose-6-phosphate dehydrogenase) This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
G6PD Gene-Disease associations (from GenCC):
  • anemia, nonspherocytic hemolytic, due to G6PD deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • G6PD deficiency
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • class I glucose-6-phosphate dehydrogenase deficiency
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 7 ACMG points.

PM1
In a hotspot region, there are 7 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 3 uncertain in NM_001360016.2
PM5
Other missense variant is known to change same aminoacid residue: Variant chrX-154534125-C-A is described in ClinVar as Pathogenic. ClinVar VariationId is 10387.Status of the report is no_assertion_criteria_provided, 0 stars.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 185 curated pathogenic missense variants (we use a threshold of 10). The gene has 42 curated benign missense variants. Gene score misZ: 2.0008 (below the threshold of 3.09). Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to anemia, nonspherocytic hemolytic, due to G6PD deficiency, class I glucose-6-phosphate dehydrogenase deficiency, G6PD deficiency.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.847
PP5
Variant X-154534125-C-T is Pathogenic according to our data. Variant chrX-154534125-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 10395.
BS2
High Hemizygotes in GnomAd4 at 6 XL geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
G6PDNM_001360016.2 linkc.680G>A p.Arg227Gln missense_variant Exon 7 of 13 ENST00000393562.10 NP_001346945.1
G6PDNM_000402.4 linkc.770G>A p.Arg257Gln missense_variant Exon 7 of 13 NP_000393.4 P11413-3
G6PDNM_001042351.3 linkc.680G>A p.Arg227Gln missense_variant Exon 7 of 13 NP_001035810.1 P11413-1A0A384NL00

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
G6PDENST00000393562.10 linkc.680G>A p.Arg227Gln missense_variant Exon 7 of 13 1 NM_001360016.2 ENSP00000377192.3 P11413-1

Frequencies

GnomAD3 genomes
AF:
0.0000713
AC:
8
AN:
112270
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000750
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000491
AC:
9
AN:
183199
AF XY:
0.000103
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000182
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000490
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000628
AC:
69
AN:
1098140
Hom.:
0
Cov.:
32
AF XY:
0.0000660
AC XY:
24
AN XY:
363506
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26401
American (AMR)
AF:
0.000170
AC:
6
AN:
35204
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30202
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54142
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40502
Middle Eastern (MID)
AF:
0.000243
AC:
1
AN:
4116
European-Non Finnish (NFE)
AF:
0.0000653
AC:
55
AN:
842095
Other (OTH)
AF:
0.000152
AC:
7
AN:
46092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000713
AC:
8
AN:
112270
Hom.:
0
Cov.:
23
AF XY:
0.000174
AC XY:
6
AN XY:
34432
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30904
American (AMR)
AF:
0.000750
AC:
8
AN:
10672
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2645
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3562
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2717
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6216
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
236
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53132
Other (OTH)
AF:
0.00
AC:
0
AN:
1502
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000235
Hom.:
0
Bravo
AF:
0.000121
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.0000412
AC:
5
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000356

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:4Uncertain:2Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Anemia, nonspherocytic hemolytic, due to G6PD deficiency Pathogenic:3Uncertain:1
Aug 12, 2022
Dunham Lab, University of Washington
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:curation

Variant found in hemizygote with deficiency (PP4). Decreased activity in red blood cells (35%) (PS3). Affects same amino acid as pathogenic 227R>L (ClinVar ID 10387) (PM5). Below expected carrier frequency in gnomAD (PM2). Reported as pathogenic by ARUP Laboratories (PP5). Post_P 0.994 (odds of pathogenicity 1517, Prior_P 0.1). -

Jun 14, 2022
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

- -

May 04, 2022
Mendelics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 23, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 227 of the G6PD protein (p.Arg227Gln). This variant is present in population databases (rs137852328, gnomAD 0.02%). This missense change has been observed in individual(s) with G6PD deficiency (PMID: 1611091). This variant is also known as G6PD Mexico City. ClinVar contains an entry for this variant (Variation ID: 10395). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt G6PD protein function. Experimental studies have shown that this missense change affects G6PD function (PMID: 25407525). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant disrupts the p.Arg227 amino acid residue in G6PD. Other variant(s) that disrupt this residue have been observed in individuals with G6PD-related conditions (PMID: 10571945), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Pathogenic:1
Sep 21, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

G6PD deficiency Uncertain:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

G6PD MEXICO CITY Other:1
May 24, 2017
OMIM
Significance:other
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Pathogenic
0.25
D
BayesDel_noAF
Pathogenic
0.40
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.98
D;D;D;.;D;.;D
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.94
.;.;D;D;D;D;D
M_CAP
Pathogenic
0.63
D
MetaRNN
Pathogenic
0.85
D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Uncertain
2.8
M;M;M;M;.;.;.
PhyloP100
5.5
PrimateAI
Uncertain
0.61
T
PROVEAN
Uncertain
-3.7
.;.;D;D;D;D;D
REVEL
Pathogenic
0.87
Sift
Uncertain
0.0050
.;.;D;D;D;D;D
Sift4G
Uncertain
0.0030
D;.;D;D;.;.;.
Polyphen
0.94
P;P;P;.;.;.;.
Vest4
0.75
MVP
1.0
MPC
1.3
ClinPred
0.43
T
GERP RS
3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.94
gMVP
0.98
Mutation Taster
=45/55
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137852328; hg19: chrX-153762340; API